Glenmark gets FDA green light for generic Welchol

Press enter to search
Close search
Open Menu

Glenmark gets FDA green light for generic Welchol

By Sandra Levy - 07/17/2018
Glenmark Pharmaceuticals has received the OK from the Food and Drug Administration for the generic version of Daiichi Sankyo’s Welchol (colesevelam hydrocholoride) for oral suspension in 1.875 g/packet and 3.75 g/packet.

The product is intended to lower LDL or “bad” cholesterol.

Welchol for oral suspension had a market value of approximately $73 million for the 12 month period ending May 2018, according to IQVIA data.

Related Topics